S&P 500   4,486.46 (+0.34%)
DOW   35,258.61 (-0.10%)
QQQ   372.48 (+0.96%)
AAPL   146.61 (+1.22%)
MSFT   306.87 (+0.87%)
FB   335.39 (+3.27%)
GOOGL   2,851.10 (+0.84%)
TSLA   869.59 (+3.15%)
AMZN   3,445.90 (+1.08%)
NVDA   221.92 (+1.51%)
BABA   167.16 (-0.50%)
NIO   39.48 (+4.69%)
CGC   13.20 (-1.12%)
GE   104.17 (-0.23%)
MU   67.18 (-0.74%)
AMD   116.19 (+3.63%)
T   25.32 (-1.48%)
F   15.58 (-0.76%)
ACB   6.93 (-1.42%)
DIS   171.30 (-2.92%)
PFE   41.34 (-0.36%)
BA   216.88 (-0.07%)
AMC   43.01 (+5.57%)
S&P 500   4,486.46 (+0.34%)
DOW   35,258.61 (-0.10%)
QQQ   372.48 (+0.96%)
AAPL   146.61 (+1.22%)
MSFT   306.87 (+0.87%)
FB   335.39 (+3.27%)
GOOGL   2,851.10 (+0.84%)
TSLA   869.59 (+3.15%)
AMZN   3,445.90 (+1.08%)
NVDA   221.92 (+1.51%)
BABA   167.16 (-0.50%)
NIO   39.48 (+4.69%)
CGC   13.20 (-1.12%)
GE   104.17 (-0.23%)
MU   67.18 (-0.74%)
AMD   116.19 (+3.63%)
T   25.32 (-1.48%)
F   15.58 (-0.76%)
ACB   6.93 (-1.42%)
DIS   171.30 (-2.92%)
PFE   41.34 (-0.36%)
BA   216.88 (-0.07%)
AMC   43.01 (+5.57%)
S&P 500   4,486.46 (+0.34%)
DOW   35,258.61 (-0.10%)
QQQ   372.48 (+0.96%)
AAPL   146.61 (+1.22%)
MSFT   306.87 (+0.87%)
FB   335.39 (+3.27%)
GOOGL   2,851.10 (+0.84%)
TSLA   869.59 (+3.15%)
AMZN   3,445.90 (+1.08%)
NVDA   221.92 (+1.51%)
BABA   167.16 (-0.50%)
NIO   39.48 (+4.69%)
CGC   13.20 (-1.12%)
GE   104.17 (-0.23%)
MU   67.18 (-0.74%)
AMD   116.19 (+3.63%)
T   25.32 (-1.48%)
F   15.58 (-0.76%)
ACB   6.93 (-1.42%)
DIS   171.30 (-2.92%)
PFE   41.34 (-0.36%)
BA   216.88 (-0.07%)
AMC   43.01 (+5.57%)
S&P 500   4,486.46 (+0.34%)
DOW   35,258.61 (-0.10%)
QQQ   372.48 (+0.96%)
AAPL   146.61 (+1.22%)
MSFT   306.87 (+0.87%)
FB   335.39 (+3.27%)
GOOGL   2,851.10 (+0.84%)
TSLA   869.59 (+3.15%)
AMZN   3,445.90 (+1.08%)
NVDA   221.92 (+1.51%)
BABA   167.16 (-0.50%)
NIO   39.48 (+4.69%)
CGC   13.20 (-1.12%)
GE   104.17 (-0.23%)
MU   67.18 (-0.74%)
AMD   116.19 (+3.63%)
T   25.32 (-1.48%)
F   15.58 (-0.76%)
ACB   6.93 (-1.42%)
DIS   171.30 (-2.92%)
PFE   41.34 (-0.36%)
BA   216.88 (-0.07%)
AMC   43.01 (+5.57%)
NASDAQ:NURO

NeuroMetrix Short Interest Ratio and Short Volume

$9.10
+0.10 (+1.11 %)
(As of 10/18/2021 03:52 PM ET)
Add
Compare
Today's Range
$9.01
$9.66
50-Day Range
$8.62
$16.51
52-Week Range
$1.47
$38.75
Volume9,457 shs
Average Volume3.56 million shs
Market Capitalization$51.22 million
P/E RatioN/A
Dividend YieldN/A
Beta3.05

NeuroMetrix (NASDAQ:NURO) Short Interest Data

Current Short Volume525,600 shares
Previous Short Volume411,000 shares
Change Vs. Previous Month+27.88%
Dollar Volume Sold Short$5.33 million
Short Interest Ratio / Days to Cover0.1
Last Record DateSeptember, 30 2021
Outstanding Shares5,629,000 shares
Percentage of Shares Shorted9.34%
Today's Trading Volume9,457 shares
Average Trading Volume3,557,716 shares
Today's Volume Vs. Average-99.73%

Days to Cover Over Time

Percentage of Float Shorted Over Time

cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling NeuroMetrix ?

Sign up to receive the latest short interest report for NeuroMetrix and its competitors with MarketBeat's FREE newsletter.

NeuroMetrix (NASDAQ:NURO) Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
9/30/2021525,600 shares $5.33 million +27.9%N/A0.1 $10.14
9/15/2021411,000 shares $4.59 million -64.0%N/A0 $11.18
8/31/20211,140,000 shares $13.61 million +169.3%N/A0.1 $11.94
8/13/2021423,400 shares $5.17 million -66.9%N/A0.1 $12.20
7/30/20211,280,000 shares $19.07 million +4,124.4%N/A0.2 $14.90
7/15/202130,300 shares $98,172.00 -10.4%N/A0 $3.24
6/30/202133,800 shares $115,258.00 -6.1%0.9%0.3 $3.41
6/15/202136,000 shares $122,400.00 -15.7%1.0%0.3 $3.40
5/28/202142,700 shares $124,684.00 -41.8%1.1%0.5 $2.92
5/14/202173,400 shares $199,648.00 +72.3%2.0%0.9 $2.72
4/30/202142,600 shares $129,930.00 +62.0%1.1%0.3 $3.05
4/15/202126,300 shares $89,157.00 +11.4%0.7%0.1 $3.39
3/31/202123,600 shares $78,588.00 -19.7%0.6%0.1 $3.33
3/15/202129,400 shares $108,780.00 +950.0%0.8%0.1 $3.70
2/26/20212,800 shares $9,688.00 -81.1%0.1%0 $3.46
2/12/202114,800 shares $64,084.00 -42.9%0.4%0 $4.33
1/29/202125,900 shares $102,046.00 -80.4%0.7%0 $3.94
1/15/2021132,300 shares $455,112.00 -26.0%3.5%0.1 $3.44
12/31/2020178,700 shares $568,266.00 -41.5%4.8%0.1 $3.18
12/15/2020305,200 shares $747,740.00 +80.8%8.1%0.2 $2.45
11/30/2020168,800 shares $344,352.00 +2.2%4.5%0.1 $2.04
11/15/2020165,200 shares $282,492.00 -4.1%4.4%0.9 $1.71
10/30/2020172,300 shares $258,450.00 +6.2%4.6%0.8 $1.50
10/15/2020162,200 shares $277,362.00 -11.0%4.3%0.6 $1.71
9/30/2020182,200 shares $309,740.00 -6.6%4.9%0.6 $1.70

NeuroMetrix (NASDAQ:NURO) Short Interest FAQ













NeuroMetrix (NASDAQ:NURO) Short Interest Frequently Asked Questions

What is NeuroMetrix's current short interest?

Short interest is the volume of NeuroMetrix shares that have been sold short but have not yet been closed out or covered. As of September 30th, investors have sold 525,600 shares of NURO short. Learn More on NeuroMetrix's current short interest.

Is NeuroMetrix's short interest increasing or decreasing?

NeuroMetrix saw a increase in short interest during the month of September. As of September 30th, there was short interest totaling 525,600 shares, an increase of 27.9% from the previous total of 411,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does NeuroMetrix's short interest compare to its competitors?

0.00% of NeuroMetrix's shares are currently sold short. Here is how the short interest of companies in the industry of "surgical & medical instruments" compare to NeuroMetrix: Liquidia Co. (1.89%), TELA Bio, Inc. (1.18%), Titan Medical Inc. (0.00%), Nemaura Medical Inc. (4.18%), T2 Biosystems, Inc. (0.00%), Neuronetics, Inc. (8.96%), BrainsWay Ltd. (0.00%), PolyPid Ltd. (0.13%), Repro Med Systems, Inc. (1.85%), and Venus Concept Inc. (3.82%).

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: S&P Global Inc. ($7.35 billion), Advanced Micro Devices, Inc. ($6.43 billion), Charter Communications, Inc. ($5.68 billion), Wayfair Inc. ($4.48 billion), Uber Technologies, Inc. ($3.77 billion), Canadian Pacific Railway Limited ($3.73 billion), Palo Alto Networks, Inc. ($3.10 billion), Zoom Video Communications, Inc. ($2.87 billion), Match Group, Inc. ($2.83 billion), and DoorDash, Inc. ($2.54 billion). View all of the most shorted stocks.

What does it mean to sell short NeuroMetrix stock?

Short selling NURO is an investing strategy that aims to generate trading profit from NeuroMetrix as its price is falling. NeuroMetrix's stock is trading up $0.10 today. To short NeuroMetrix stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that NeuroMetrix will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against NeuroMetrix?

A short squeeze for NeuroMetrix occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of NURO, which in turn drives the price of the stock up even further.

How often is NeuroMetrix's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including NURO, twice per month. The most recent reporting period available is September, 30 2021.



This page was last updated on 10/18/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.